Featured series 
Tag: T cells
-
Health
How serious is FDA warning about revolutionary blood-cancer treatment?
Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease
-
Health
Research shows working out gets inflammation-fighting T cells moving
Activated by regular exercise, immune cells in muscles found to fend off inflammation, enhance endurance in mice
-
Health
Torn muscle? Send in the gut microbes for rapid repair
A Harvard-led study shows that the gut microbiota acts as the training camp for a class of immune cells that are recruited to heal muscle injury.
-
Health
Interaction between immune factors can trigger cancer
Harvard researchers found that interaction between immune factors triggers cancer-promoting chronic inflammation, setting the stage for the development of skin cancer associated with chronic dermatitis and colorectal cancer in patients with colitis.
-
Health
New approach to cancer treatment carries success with caveat
Restoring the cancer-killing zeal of T cells is being seen as one of the most successful new approaches to cancer treatment in nearly a decade, although researchers note it has shown effectiveness in only about a quarter of cases.
-
Health
Vitamin D protects some against colorectal cancer
A new study by investigators at Dana-Farber Cancer Institute demonstrates that vitamin D can protect some people with colorectal cancer by perking up the immune system’s vigilance against tumor cells.
-
Health
Discovering where HIV persists in spite of treatment
HIV antiviral therapy lets infected people live relatively healthy lives for many years, but the virus doesn’t go away completely. If treatment stops, the virus multiplies again from hidden reservoirs in the body. Researchers may have found HIV’s viral hiding place — in a small group of recently identified T cells with stem cell-like properties.
-
Health
New hope against diabetes
Results from a phase 1 drug trial by Harvard Medical School and Massachusetts General Hospital researchers showed that a decades-old tuberculosis drug knocked out the autoimmune cells that attack diabetic patients’ insulin-producing cells, followed by indications that pancreatic function was improving, albeit transiently.
-
Health
Better odds
Test could predict which children with T-cell acute lymphoblastic leukemia are best candidates for clinical trials of new therapies, research finds.
